Fluticasone Propionate* (Fluticasone Propionate) — Medicare Part D spending
Multiple manufacturers (11) · Rank #217 by total Part D spend · CMS data year 2023
Medicare Part D spent $201,536,224 on Fluticasone Propionate* (Fluticasone Propionate) in 2023, the #217 drug by total Part D spending out of 3,598 drugs. That worked out to about $0.69 per dosage unit, $17 per claim and $41 per beneficiary, across 12,165,417 claims for 4,902,813 beneficiaries. Average spending per dosage unit fell -2.4% from 2022. These are aggregate Medicare program figures (gross drug cost), not the price you pay.
Source: CMS Medicare Part D Spending by Drug (data year 2023). Data as of June 2026.
Fluticasone Propionate* (Fluticasone Propionate) spending at a glance (2023)
| Metric | Fluticasone Propionate* (Fluticasone Propionate) |
|---|---|
| Total Part D spending (2023) | $201,536,224 |
| Total spending (2022) | $201,842,015 |
| Year-over-year change in total spending | -0.2% |
| Average spending per dosage unit (2023) | $0.69 |
| Change in spend per dosage unit (YoY) | -2.4% |
| Avg annual change per dosage unit (2019-2023 CAGR) | +0.3% |
| Average spending per claim (2023) | $17 |
| Average spending per beneficiary (2023) | $41 |
| Total claims (2023) | 12,165,417 |
| Beneficiaries (2023) | 4,902,813 |
| Total dosage units (2023) | 294,139,968 |
| Manufacturer(s) | Multiple manufacturers (11) |
| National rank by total spend (of 3,598 drugs) | #217 |
Source: CMS Medicare Part D Spending by Drug (data year 2023). Data as of June 2026.
2022 vs 2023
| Metric | 2022 | 2023 | Change |
|---|---|---|---|
| Total spending | $201,842,015 | $201,536,224 | -0.2% |
| Avg spend per dosage unit | $0.70 | $0.69 | -2.4% |
| Avg spend per claim | $17 | $17 | — |
| Avg spend per beneficiary | $43 | $41 | — |
| Total claims | 11,770,158 | 12,165,417 | — |
| Beneficiaries | 4,646,122 | 4,902,813 | — |
How Fluticasone Propionate* compares with nearby drugs
Drugs with total Part D spending closest to Fluticasone Propionate* (Fluticasone Propionate):
| Drug (rank) | Total spend 2023 | Per dosage unit | Per-unit YoY |
|---|---|---|---|
| Fluticasone Propionate* (Fluticasone Propionate) (this drug, #217) | $201,536,224 | $0.69 | -2.4% |
| Famotidine* (Famotidine) (#215) | $202,810,000 | $0.20 | +4.2% |
| Clopidogrel (Clopidogrel Bisulfate) (#216) | $201,696,339 | $0.24 | -1.0% |
| Quetiapine Fumarate (#218) | $201,087,913 | $0.42 | -27.7% |
| Vyvgart (Efgartigimod Alfa-Fcab) (#219) | $200,002,141 | $315.30 | +1.9% |
| Bosulif (Bosutinib) (#220) | $199,137,491 | $369.42 | +11.3% |
Frequently asked questions
How much does Medicare Part D spend on Fluticasone Propionate*?
Medicare Part D spent $201,536,224 on Fluticasone Propionate* (Fluticasone Propionate) in 2023 (the latest CMS data year), across 12,165,417 claims for 4,902,813 beneficiaries. That ranks #217 of 3,598 drugs by total Part D spending. This is gross drug cost (Medicare, plan and beneficiary payments combined), not the price you personally pay.
What is the average spending per dosage unit for Fluticasone Propionate*?
In 2023, the weighted average Medicare Part D spending per dosage unit for Fluticasone Propionate* (Fluticasone Propionate) was $0.69. Compared with 2022 it fell -2.4%. A "dosage unit" is one pill, tablet, milliliter or other billing unit, so this is not the price of a prescription.
Who makes Fluticasone Propionate*?
CMS attributes Fluticasone Propionate* (Fluticasone Propionate) to Multiple manufacturers (11) in the 2023 Part D spending file. Average spending per claim was $17 and per beneficiary $41.
Is the Fluticasone Propionate* figure the price I pay?
No. These are aggregate Medicare Part D program figures (total gross drug cost and averages across all claims), published by CMS for transparency. Your out-of-pocket cost depends on your plan, formulary, deductible and coverage phase. Always check your plan and talk to your pharmacist or doctor.
Keep exploring
Source & what this means
Figures are from the CMS Medicare Part D Spending by Drug dataset (data year 2023, US public domain). "Total spending" is the gross drug cost — Medicare, plan and beneficiary payments combined — for Part D claims; it is not a list price, a negotiated price, or what any individual pays. Spending per dosage unit is volume-weighted across formulations. This is general public-spending information, not medical or pricing advice. Your own cost depends on your plan, deductible and coverage phase — verify with your Part D plan and a pharmacist. Data as of June 2026. See our methodology and disclaimer.
Last updated: 2026-06-20